Charles Moore has a long-proven track record in both print and digital journalism, touching on a wide range of subjects, from biotech and healthcare to politics and technology. He contributes substantial feature articles about RA research and development for the news site.
The US Food and Drug Administration’s (FDA) Arthritis Advisory Committee last month unanimously supported Amgen’s drug candidate ABP 501 as a ... Read more
Global pharmaceutical and healthcare products company GlaxoSmithKline (GSK) has launched the “Patient Rheumatoid Arthritis Data from the Real World” (PARADE) clinical ... Read more
The U.S. Food and Drug Administration (FDA) held Arthritis Advisory Committee Meetings, July 11-12 in Maryland, and discussed Biologics License Applications (BLA) approvals, including ... Read more
Southborough, Massachusetts-based Corrona LLC, independent specialists in the compilation of real-world evidence and consulting on auto-immune disorders, is represented at EULAR 2016 ... Read more
Myriad Genetics, Inc., a personalized medicine subsidiary of Crescendo Bioscience, has launched a new web portal called myVectra for people with rheumatoid arthritis (RA). myVectra ... Read more
Vienna, Virginia-based CEL-SCI Corporation, a biopharmaceutical company focused on research and development directed at disease treatments that utilize the immune system’s ... Read more
Basel, Switzerland based multinational pharma giant Roche has been granted breakthrough therapy designation (BTD) status by the U.S. Food and Drug ... Read more
Upper Nyack, N.Y. based online non-profit organization CreakyJoints, with a support community of more than 80,000 patients and their families in ... Read more
